Purpose of Review

The past two decades has seen an influx of noninvasive neuromodulation devices aimed at treatment of various primary headache disorders, including cluster headache and migraine. This narrative review is to summarize the current options in noninvasive neuromodulation in migraine.

Recent Findings

A variety of noninvasive neuromodulation devices have been FDA cleared and marketed for use in migraine, including single-pulse transcranial magnetic stimulation (sTMS), noninvasive vagal nerve stimulators (nVNS), and external trigeminal nerve stimulators (eTNS). Newer devices include peripheral electrical stimulation devices (PES), caloric stimulation, and others. Each has varying levels of evidence supporting its use in migraine, tolerability profiles, and access issues.

Summary

Noninvasive neuromodulation devices can be beneficial when used in patients with migraine, with minimal side effects. As more devices are developed, approved, and marketed in the future, rigorous research on efficacy and safety remain a top priority.

中文翻译：

---

偏头痛的无创神经调节

审查目的

在过去的二十年里，大量无创神经调节设备涌入，旨在治疗各种原发性头痛疾病，包括丛集性头痛和偏头痛。这篇叙述性综述旨在总结偏头痛无创神经调节的当前选择。

最近的发现

多种无创神经调节装置已被 FDA 批准并上市用于偏头痛，包括单脉冲经颅磁刺激 (sTMS)、无创迷走神经刺激器 (nVNS) 和外部三叉神经刺激器 (eTNS)。较新的设备包括外周电刺激设备 (PES)、热量刺激等。每个都有不同级别的证据支持其在偏头痛、耐受性概况和访问问题中的使用。

概括

当用于偏头痛患者时，无创神经调节装置可能是有益的，并且副作用最小。随着未来更多设备的开发、批准和上市，对有效性和安全性的严格研究仍然是重中之重。